Emily Welebob

922 total citations
15 papers, 658 citations indexed

About

Emily Welebob is a scholar working on Health Information Management, Toxicology and Occupational Therapy. According to data from OpenAlex, Emily Welebob has authored 15 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Health Information Management, 3 papers in Toxicology and 2 papers in Occupational Therapy. Recurrent topics in Emily Welebob's work include Electronic Health Records Systems (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Ethics in Clinical Research (2 papers). Emily Welebob is often cited by papers focused on Electronic Health Records Systems (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Ethics in Clinical Research (2 papers). Emily Welebob collaborates with scholars based in United States, Netherlands and United Kingdom. Emily Welebob's co-authors include Abraham G. Hartzema, Patrick Ryan, Paul Stang, J. Marc Overhage, Christian Reich, Janet Woodcock, Judith A. Racoosin, David C. Classen, Jane Metzger and David W. Bates and has published in prestigious journals such as Annals of Internal Medicine, Health Affairs and Drug Safety.

In The Last Decade

Emily Welebob

15 papers receiving 629 citations

Peers

Emily Welebob
Comparison fields: 5 of 95
  • Health Information Management 207
  • Toxicology 196
  • Molecular Biology 117
  • Statistics and Probability 102
  • Computational Theory and Mathematics 88
Frantz Thiessard France
Judith C. Maro United States
Pedro J. Caraballo United States
Chris Kelman Australia
Lisa E. Hines United States
Nicholas S. Downing United States
Krystl Haerian United States
Birgit Eiermann Sweden
Janet Marchibroda United States
Louisa Walsh Australia
Frantz Thiessard France View profile →
Citations per field, relative to Emily Welebob
Emily Welebob · 1×
Citations per year, relative to Emily Welebob
Emily Welebob · 1×

Countries citing papers authored by Emily Welebob

Since Specialization
Citations

This map shows the geographic impact of Emily Welebob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Welebob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Welebob more than expected).

Fields of papers citing papers by Emily Welebob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Welebob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Welebob. The network helps show where Emily Welebob may publish in the future.

Co-authorship network of co-authors of Emily Welebob

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Welebob. A scholar is included among the top collaborators of Emily Welebob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Welebob. Emily Welebob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
# Title Journal Authors Indexed citations
1 Defining a Reference Set to Support Methodological Research in Drug Safety Drug Safety Patrick Ryan, Martijn J. Schuemie et al. 96
2 Variation in Choice of Study Design: Findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) Survey Drug Safety Paul Stang, Patrick Ryan et al. 9
3 Managing Data Quality for a Drug Safety Surveillance System Drug Safety Abraham G. Hartzema, Christian Reich et al. 15
4 Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership Annals of Internal Medicine Paul Stang, Patrick Ryan et al. 315
5 Mixed Results In The Safety Performance Of Computerized Physician Order Entry Health Affairs Jane Metzger, Emily Welebob et al. 130
6 Surveying US Observational Data Sources and Characteristics for Drug Safety Needs Pharmaceutical Medicine Patrick Ryan, Emily Welebob et al. 8
7 Health information exchange Nursing Management Emily Welebob 1
8 Taking the measure of inpatient EHRs. Hospitals inch closer to certified products. PubMed Jane Metzger, Emily Welebob et al. 1
9 HIE takes shape in the states. PubMed Mark E. Frisse, Janet Marchibroda et al. 4
10 Understanding Hospital Readiness for Computerized Physician Order Entry PubMed Emily Welebob, Elizabeth Johnson et al. 34
11 Mapping Nursing Diagnosis Nomenclatures for Coordinated Care Image the Journal of Nursing Scholarship Rita D. Zielstorff, Emily Welebob et al. 24
12 A Knowledge-Based Decision Support System for Prevention and Treatment of Pressure Ulcers Studies in health technology and informatics Rita D. Zielstorff, G. Octo Barnett et al. 1
13 End-User Satisfaction of a Patient Education Tool Manual Versus Computer-Generated Tool CIN Computers Informatics Nursing Emily Welebob et al. 6
14 A decision support system for prevention and treatment of pressure ulcers based on AHCPR guidelines. PubMed Rita D. Zielstorff, G. Octo Barnett et al. 12
15 Efficacy and safety of a rapid-sequence metaproterenol protocol in the treatment of acute adult asthma The American Journal of Emergency Medicine David Jerrard, Jonathan S. Olshaker et al. 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026